 |
Articles: Pharmacology/Therapy |
Prior Articles
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic phase chronic myeloid leukemia patients treated with imatinib
Blood, 11/02/09 Concordant Gene Expression Signatures Predict Clinical Outcomes of Cancer Patients Undergoing Systemic Therapy
Cancer Research, 11/02/09
Exclusive Author Commentary Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Cancer Research, 11/02/09
Exclusive Author Commentary Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
Journal of Clinical Oncology, 10/30/09 Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: The FOCUS Trial
Journal of Clinical Oncology, 10/30/09 Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09 Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Blood, 10/30/09 Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09
Free full text
Lapatinib in metastatic breast cancer
Women's Health, 10/30/09 Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors
International Journal of Clinical Oncology, 10/30/09 Chemotherapy for lung cancer: the state of the art in 2009
Expert Review of Anticancer Therapy, 10/30/09 MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
Annals of Oncology, 10/30/09 Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
International Journal of Clinical Oncology, 10/30/09 Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Journal of Hematology & Oncology, 10/30/09
Free full text
Meningeal dissemination from an ovarian carcinoma with effective response to intrathecal chemotherapy
International Journal of Clinical Oncology, 10/30/09 Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
Annals of Hematology, 10/30/09 Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens
International Journal of Clinical Oncology, 10/30/09 Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX)
International Journal of Clinical Oncology, 10/30/09 Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Leukemia and Lymphoma, 10/30/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
